[Skip to Content]
[Skip to Content Landing]
Article
March 1977

Induction of Subcapsular Cataracts in Cynomolgus Monkeys by Echothiophate

Author Affiliations

From the Department of Medical Pharmacology, University of Uppsala, Uppsala, Sweden (Drs Kaufman and Bárány), the Department of Ophthalmology, University of Wisconsin Medical School, Madison, Wis (Dr Kaufman), and the Department of Ophthalmology, Sabbatsberg Hospital, Stockholm (Dr Axelsson).

Arch Ophthalmol. 1977;95(3):499-504. doi:10.1001/archopht.1977.04450030141021
Abstract

• Sixteen eyes of 13 cynomolgus monkeys were treated topically twice daily with echothiophate iodide. The dosages were increased gradually over several weeks to plateau levels ranging from 125 to 500 μg daily. The opposite eyes of the ten unilaterally treated monkeys received a control solution (DILUENT) identical save for the absence of echothiophate. All 16 echothiophate-treated eyes developed posterior subcapsular cataracts and 15 developed anterior subcapsular cataracts. The lenses in all ten DILUENT-treated eyes remained clear. The cataracts in the echothiophate-treated eyes strongly resembled those attributed to cholinesterase inhibitors in humans. They Were first noted from 2½ to 14 weeks after beginning echothiophate treatment. Prior total iridectomy caused a more rapid progression and/or greater severity of lens changes. Higher echothiophate dosages caused the cataracts to appear more rapidly.

(Arch Ophthalmol 95:499-504, 1977)

×